Catherine Morgan

Dr. Catherine Morgan

Cerebral Palsy Alliance Research Institute, Specialty of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in JAMA Pediatrics
Verified
Journal Article
Closed access
PDF file
INIona Novak
Iona Novak
Catherine MorganCatherine Morgan
Catherine Morgan
LALars Adde
Lars Adde
JBJames Blackman
James Blackman
RBRoslyn N. Boyd
Roslyn N. Boyd
NBNadia Badawi
Nadia Badawi
Importance Cerebral palsy describes the most common physical disability in childhood and occurs in 1 in 500 live births. Historically, the diagnosis has been made between age 12 and 24 months but now can be made before 6 months’ corrected age. Objectives To systematically review best available evidence for early, accurate diagnosis of cerebral palsy and to summarize best available evidence about cerebral palsy–specific early intervention that should follow early diagnosis to optimize neuroplasticity and function. Evidence Review This study systematically searched the literature about early diagnosis of cerebral palsy in MEDLINE (1956-2016), EMBASE (1980-2016), CINAHL (1983-2016), and the Cochrane Library (1988-2016) and by hand searching. Search terms includedcerebral palsy,diagnosis,detection,prediction,identification,predictive validity,accuracy,sensitivity, andspecificity. The study included systematic reviews with or without meta-analyses, criteria of diagnostic accuracy, and evidence-based clinical guidelines. Findings are reported according to the PRISMA statement, and recommendations are reported according to the Appraisal of Guidelines, Research and Evaluation (AGREE) II instrument. Findings Six systematic reviews and 2 evidence-based clinical guidelines met inclusion criteria. All included articles had high methodological Quality Assessment of Diagnostic Accuracy Studies (QUADAS) ratings. In infants, clinical signs and symptoms of cerebral palsy emerge and evolve before age 2 years; therefore, a combination of standardized tools should be used to predict risk in conjunction with clinical history. Before 5 months’ corrected age, the most predictive tools for detecting risk are term-age magnetic resonance imaging (86%-89% sensitivity), the Prechtl Qualitative Assessment of General Movements (98% sensitivity), and the Hammersmith Infant Neurological Examination (90% sensitivity). After 5 months’ corrected age, the most predictive tools for detecting risk are magnetic resonance imaging (86%-89% sensitivity) (where safe and feasible), the Hammersmith Infant Neurological Examination (90% sensitivity), and the Developmental Assessment of Young Children (83% C index). Topography and severity of cerebral palsy are more difficult to ascertain in infancy, and magnetic resonance imaging and the Hammersmith Infant Neurological Examination may be helpful in assisting clinical decisions. In high-income countries, 2 in 3 individuals with cerebral palsy will walk, 3 in 4 will talk, and 1 in 2 will have normal intelligence. Conclusions and Relevance Early diagnosis begins with a medical history and involves using neuroimaging, standardized neurological, and standardized motor assessments that indicate congruent abnormal findings indicative of cerebral palsy. Clinicians should understand the importance of prompt referral to diagnostic-specific early intervention to optimize infant motor and cognitive plasticity, prevent secondary complications, and enhance caregiver well-being.

21 August 2013 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
INIona Novak
Iona Novak
SMSarah Mcintyre
Sarah Mcintyre
Catherine MorganCatherine Morgan
Catherine Morgan
LCLanie Campbell
Lanie Campbell
LDLeigha Dark
Leigha Dark
SGShona Goldsmith
Shona Goldsmith

21 September 2021 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
MJMichelle Jackman
Michelle Jackman
LSLeanne Nott Sakzewski
Leanne Nott Sakzewski
Catherine MorganCatherine Morgan
Catherine Morgan
RBRoslyn Boyd
Roslyn Boyd
SBSue E Brennan
Sue E Brennan
INIona Novak
Iona Novak

29 March 2016 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
Catherine MorganCatherine Morgan
Catherine Morgan
JDJohanna Darrah
Johanna Darrah
AGAndrew Gordon
Andrew Gordon
RHRegina Harbourne
Regina Harbourne
Alicia Jane SpittleAlicia Jane Spittle
Alicia Jane Spittle
LFLinda Fetters
Linda Fetters

1 November 2011 in Developmental Disabilities Research Reviews
Verified
Journal Article
Closed access
PDF file
SMSarah McIntyre
Sarah McIntyre
Catherine MorganCatherine Morgan
Catherine Morgan
KWKaren Walker
Karen Walker
INIona Novak
Iona Novak

4 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VMViviana Marchi
Viviana Marchi
ABArend F Bos
Arend F Bos
MKMagdalena Krieber-Tomantschger
Magdalena Krieber-Tomantschger
EAElsa Alvarado
Elsa Alvarado
VBVanessa Barbosa
Vanessa Barbosa
PMPeter Marschik
Peter Marschik
The Prechtl General Movement Assessment (GMA) has become a cornerstone assessment in early identification of cerebral palsy (CP), particularly during the fidgety movement period at 3–5 months of age. Additionally, assessment of motor repertoire, such as antigravity movements and postural patterns, which form the Motor Optimality Score (MOS), may provide insight into an infant’s later motor function. This study aimed to identify early specific markers for ambulation, gross motor function (using the Gross Motor Function Classification System, GMFCS), topography (unilateral, bilateral), and type (spastic, dyskinetic, ataxic, and hypotonic) of CP in a large worldwide cohort of 468 infants. We found that 95% of children with CP did not have fidgety movements, with 100% having non-optimal MOS. GMFCS level was strongly correlated to MOS. An MOS > 14 was most likely associated with GMFCS outcomes I or II, whereas GMFCS outcomes IV or V were hardly ever associated with an MOS > 8. A number of different movement patterns were associated with more severe functional impairment (GMFCS III–V), including atypical arching and persistent cramped-synchronized movements. Asymmetrical segmental movements were strongly associated with unilateral CP. Circular arm movements were associated with dyskinetic CP. This study demonstrated that use of the MOS contributes to understanding later CP prognosis, including early markers for type and severity.